“华西研究”小程序全面升级！专业研值，一镜到底！华西医药公司发布2025年中报：25H1实现营业收入207.99亿元，同比增长20.64%、实现归母净利润85.61亿元，同比增长101.92%、实现扣非净利润55.82亿元，同比增长26.47%、经调整Non-IFRS归属于上市公司股东的净利润为63.15亿元，同比增长44.4%。（一）业绩延续快速增长，在手订单维持高速增长公司持续经营业务25H1...
Source Link“华西研究”小程序全面升级！专业研值，一镜到底！华西医药公司发布2025年中报：25H1实现营业收入207.99亿元，同比增长20.64%、实现归母净利润85.61亿元，同比增长101.92%、实现扣非净利润55.82亿元，同比增长26.47%、经调整Non-IFRS归属于上市公司股东的净利润为63.15亿元，同比增长44.4%。（一）业绩延续快速增长，在手订单维持高速增长公司持续经营业务25H1...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.